Saturday, May 30, 2020

M&M FIN MIGHT BE OPRTUNITY FOR BUY


TORRENT PHARMA MIGHT SEE PULL BACK


GRASIM @ crucial level


Wednesday, May 27, 2020

TCS LOOKS GOOD FOR INVESTENT


Friday, May 22, 2020

BANDHAN BANK DIE OR SURVIVAL


Tuesday, May 19, 2020

TVS MOTOR MIGHT SEE DOWN TREND


M&M FIN at crucial level


Tuesday, May 12, 2020

Indigo might see pullback


HDFC AT EDGE


Argentina on the brink


Argentina will extend negotiations over a $65 billion debt restructuring proposal until May 22, the government said on Monday, setting the stage for tense last-ditch talks as the South American nation races to avoid default. The new deadline, which comes after an initial cut-off passed on Friday without the support needed for a comprehensive deal, means the offer will expire the same day Argentina could trigger default over a $500 million interest payment. The major grains producer is racing to revamp unsustainable debts amid a painful recession, high inflation and increasingly expensive borrowing costs as concerns over a potential ninth sovereign default have rattled investors and hit bond prices.The talks so far have been complex, with three major creditor groups rejecting the initial proposal and pushing for improved terms. Argentine officials have said the country cannot afford to pay more, though they are open to counterproposals. "Clearly, both sides are playing hardball," Capital Economics said in a note on Monday, adding that the talks were likely to drag on and that creditors could face large haircuts, especially with the global coronavirus pandemic sapping growth. "The government is facing ever-growing demands on its purse as the health crisis continues," it said. "Accordingly, recovery rates for foreign bondholders of around 30% are looking increasingly likely." Analysts calculate that the current offer, which includes a three-year payment halt, a large cut to coupon payments and maturities pushed back to 2030 and beyond amounts to a net present value of around 30-35%.

Covid - 19 Impact on WH

WH OFFICIAL CONFIRMS THAT WHITE HOUSE STAFF ARE NOW BEING ASKED TO WEAR MASKS WHILE INSIDE THE BUILDING, EXCEPT AT THEIR OWN DESKS

Naukri at crucial level


Monday, May 11, 2020

Torrent Pha. might see break out


CIPLA might see down fall

Sunday, May 10, 2020

TORRENT POWER CRUCIAL LEVEL


JUSTDIAL MIGHT SEE DOWN SIDE


TVS MOTOR CRUCIAL LEVEL 310


Wednesday, May 6, 2020

BAJAJ FINACE MIGHT GIVE RECOVERY


US - China Trade War

China said on Wednesday tariffs should not be used as a weapon after U.S. President Donald Trump threatened to impose more of them in retaliation for China's handling of the novel coronavirus.

Tariffs, in general, hurt all parties involved, Chinese foreign ministry spokeswoman Hua Chunying told reporters at a daily briefing.

"So the United States should stop thinking it can use tariffs as a weapon and a big stick to coerce other countries," she said.

Trump said on Friday that raising tariffs on China was "certainly an option" as he considers ways to retaliate for the coronavirus pandemic. 

US president Want to Reopen US Economy

President Donald Trump appeared to accept the risk of subsequent waves of infection on Tuesday, saying of his push to reopen the economy: ““Will some people be affected? Yes. Will some people be affected badly? Yes. But we have to get our country open and we have to get it open soon.”

Tuesday, May 5, 2020

MOTHERSUMI MIGHT SEE DOWN SIDE


Monday, May 4, 2020

US - CHINA

U.S. Secretary of State Mike Pompeo said on Sunday there was "a significant amount of evidence" that the coronavirus emerged from a Chinese laboratory, but did not dispute U.S. intelligence agencies' conclusion that it was not man-made.

Pompeo's statement comes after Wall Street started May on a grim note as President Donald Trump revived a threat of new tariffs against China in response to the COVID-19 pandemic.

apollo hsp might see down side below 1370


Saturday, May 2, 2020

Covid-19 , FDA approved Antivirul Drug

The Food and Drug Administration authorized the emergency use of the drug remdesivir in Covid-19 patients after researchers reported that it shortened the recovery times in people who have fallen ill from the new coronavirus.

The FDA action limits the use of the drug, produced by Gilead Sciences Inc., for only through the duration of the pandemic, but health regulators could grant full approval if more benefits emerge from a large study by the National Institute of Allergy and Infectious Diseases and other clinical trials under way.



Link:- https://www.google.co.in/amp/s/www.wsj.com/amp/articles/fda-authorizes-emergency-use-of-gilead-drug-for-covid-19-patients-11588363751

Friday, May 1, 2020

MOTHERSUMI MIGHT SEE DOWNSIDE


Till date What Happen on Views

US-China trade war

U.S. President Donald Trump said on Thursday his hard-fought trade deal with China was now of secondary importance to the coronavirus pandemic and he threatened new tariffs on Beijing, as his administration crafted retaliatory measures over the outbreak.